GLISAL 60 (Gliclazide 60 mg SR) is a once-daily, sustained-release oral medication for Type 2 diabetes. It works by increasing insulin release from the pancreas, helps control blood sugar throughout the day, and is most effective when taken with breakfast. Patients should be aware of the risk of low blood sugar, take it consistently, and […]
DAPABRIGHT M 500 ER (Dapagliflozin 10 mg + Metformin 500 mg ER(Extended Release) is a high-performance combination therapy for Type 2 Diabetes Mellitus. It is typically prescribed when blood sugar levels are not sufficiently controlled by Metformin alone or when a patient requires the added heart and kidney protective benefits of an SGLT2 inhibitor. This […]
BOVOSE 0.2 (Voglibose 0.2 mg Mouth Dissolving) is an oral antidiabetic medication used primarily to control post-prandial hyperglycemia—the rapid spike in blood sugar that occurs immediately after eating. Unlike many other diabetes drugs that work on the pancreas or liver, Voglibose works entirely within the small intestine. The “Mouth Dissolving” (or Orally Disintegrating) format offers […]
BOVOSE 0.2M (Voglibose 0.2 mg + Metformin 500 mg SR) is a dual-action oral antidiabetic combination used to manage Type 2 Diabetes Mellitus. This specific formulation is often used as a starting point for combination therapy or for patients who require moderate control over both their fasting and post-meal blood sugar levels. By pairing an […]
BOVOSE 0.3 ( 0.3 mg Mouth Dissolving ) Tablets are a specialized oral antidiabetic medication designed to control the rapid rise in blood glucose levels that occurs immediately after eating (post-prandial hyperglycemia). The “Mouth Dissolving” or Orally Disintegrating Tablet (ODT) technology is a specific clinical choice to ensure the medication is active exactly when it […]
BOVOSE 0.3M ( Voglibose 0.3 mg + Metformin 500 mg SR) is a potent fixed-dose combination (FDC) designed to address two distinct challenges in Type 2 Diabetes: post-meal sugar spikes and overall insulin resistance. By combining an Alpha-Glucosidase Inhibitor (Voglibose) with a Biguanide (Metformin), this medication provides “comprehensive glycemic control” by working in both the […]
DAPABRIGHT 10 (Dapagliflozin 10 mg ) is a highly effective, modern oral antidiabetic medication used primarily to manage Type 2 Diabetes Mellitus. It belongs to a revolutionary class of drugs known as SGLT2 inhibitors (Sodium-Glucose Co-transporter 2 inhibitors), often referred to as “Gliflozins.” Unlike older diabetes medications that work on the pancreas or liver, Dapagliflozin […]
Login